Astrazeneca Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Astrazeneca stocks.

Recent Signals

Date Stock Signal Type
2021-05-11 AZN 1,2,3 Pullback Bullish Bullish Swing Setup
2021-05-11 AZN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-11 N4P Lower Bollinger Band Walk Weakness

Recent News for Astrazeneca Stocks

Date Stock Title
May 11 AZN European Union Announce Second Lawsuit Against AstraZeneca Over Delayed COVID-19 Vaccine Supply: Reuters
May 11 AZN Argentina to get 4 mln AstraZeneca COVID-19 vaccines in May after delays
May 11 AZN UPDATE 1-Mexico says U.S. to share AstraZeneca vaccine after testing
May 11 AZN AstraZeneca CEO Pascal Soriot narrowly wins vote on pay raise
May 11 AZN UPDATE 2-Canada's Alberta province halts AstraZeneca vaccine first shots due to supply issue
May 11 AZN UPDATE 1-AstraZeneca investors narrowly approve CEO's 2021 pay package
May 11 AZN AstraZeneca suffers big revolt over Pascal Soriot’s pay
May 11 AZN AstraZeneca runs into 'meaningful' investor revolt over pay
May 11 AZN Novavax Down Second Straight Day On Concerns About Delays
May 11 AZN UPDATE 3-Brazil suspends use of AstraZeneca vaccine in pregnant women nationally after death
May 11 AZN Will the Blood Clot Issue Hurt AstraZeneca's Vaccine in the Long Term?
May 11 AZN How Will the U.S. Glut of Coronavirus Vaccines Affect Manufacturers?
May 11 AZN UPDATE 2-Britain open to talks over vaccine waivers with U.S, others at WTO
May 11 AZN UPDATE 4-EU opens new front in AstraZeneca legal fight that may lead to fines
May 11 AZN EU wants AstraZeneca to deliver 120 mln COVID vaccines by end-June
May 11 AZN AstraZeneca suffers investor rebellion over pay
May 10 AZN WHO classifies triple-mutant Covid variant from India as global health risk
May 10 AZN Was The Smart Money Right About AstraZeneca plc (AZN)?
May 10 AZN FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic
May 10 AZN COVID-19 is not at the point yet where we can have mass gatherings: Doctor

AstraZeneca plc is a British multinational pharmaceutical and biopharmaceutical company. In 2013, it moved its headquarters to Cambridge, UK, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA (location of MedImmune) for work on biopharmaceuticals; and Mölndal (near Gothenburg) in Sweden, for research on traditional chemical drugs. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.The company was founded in 1999 through the merger of the Swedish Astra AB and the English Zeneca Group (itself formed by the demerger of the pharmaceutical operations of Imperial Chemical Industries in 1993). Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014).
AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It has secondary listings on the New York Stock Exchange and the OMX exchange.

More about Astrazeneca
Browse All Tags